Lannett (NYSE: LCI)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-24 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.420 | -0.410 | 0.0100 | ||||
REV | 83.650M | 78.357M | -5.293M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Lannett (NYSE: LCI) through any online brokerage.
Other companies in Lannett’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Cumberland (NASDAQ:CPIX), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for Lannett (NYSE: LCI) was reported by Roth Capital on Tuesday, August 31, 2021. The analyst firm set a price target for 6.00 expecting LCI to rise to within 12 months (a possible 971.05% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lannett (NYSE: LCI) is $0.5602 last updated Today at July 1, 2022, 7:57 PM UTC.
There are no upcoming dividends for Lannett.
Lannett’s Q4 earnings are confirmed for Wednesday, August 24, 2022.
There is no upcoming split for Lannett.
Lannett is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.